Patents Assigned to Schaper & Bruemmer GmbH & Co.
  • Patent number: 6267994
    Abstract: Composition, including pharmaceutical compositions, containing a combination of antiestrogenic compounds. Methods of treatment using extracts of the plant Cimicifuga, alone or in combination with at least one antiestrogenic compound, which avoid or diminish unwanted side-effects and provide increased therapeutic benefit.
    Type: Grant
    Filed: August 14, 1998
    Date of Patent: July 31, 2001
    Assignee: Schaper & Bruemmer GmbH & Co. KG
    Inventors: Thomas Nesselhut, Cornelia Bodinet, Peter Schneider, Johannes Freudenstein
  • Patent number: 5525626
    Abstract: The invention relates to the use of 1,2 -benzopyrone derivatives for the treatment of susceptible malignant tumors in human beings. The derivatives used according to the invention are suitable for both preventive and also therapeutic treatment and they display in particular growth-inhibiting effect vis-a -vis brain-tumor cells and cells from human renal, prostate, skin or lung carcinomas.
    Type: Grant
    Filed: November 3, 1994
    Date of Patent: June 11, 1996
    Assignee: Schaper & Bruemmer GmbH & Co.
    Inventors: Douglas R. Thornes, Helga Stolze, Ernest Marshall, Kurt Zanker, Manly E. Marshall
  • Patent number: 5489585
    Abstract: Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections are disclosed. The compounds are particularly useful in the treatment of picornaviruses, and more particularly in the treatment of rhinoviruses.
    Type: Grant
    Filed: November 9, 1992
    Date of Patent: February 6, 1996
    Assignee: Schaper & Bruemmer GmbH & Co., KG
    Inventors: Norbert Beuscher, Helmut Ritter, Cornelia Bodinet
  • Patent number: 5466451
    Abstract: Extraction of pharmaceutically active compositions from a mixture of numerous ingredients, in particular from comminuted plants, such as Tanacetum parthenium, succeeds with a high yield and a surprisingly improved stability of the active substances when the extraction is carried out with a gas, preferably CO.sub.2, in the supercritical state.
    Type: Grant
    Filed: January 29, 1993
    Date of Patent: November 14, 1995
    Assignee: Schaper & Bruemmer GmbH & Co., KG
    Inventors: Norbert Beuscher, Ingo Willigmann
  • Patent number: 5151498
    Abstract: A glycoprotein with a molecular weight of 38 kD, isolated from the grain of Avena sativa, exhibits surprising pharmacological properties, including immunomodulating activity. The glycoprotein can be used to treat viral and bacterial infections, and can also be used to counter susceptibility to infection arising from a genetic or temporary immunodeficiency. A process for isolating the glycoprotein from Avena sativa is disclosed.
    Type: Grant
    Filed: April 30, 1990
    Date of Patent: September 29, 1992
    Assignee: Schaper & Bruemmer GmbH & Co. KG
    Inventors: Norbert Beuscher, Karl-Heinz Scheit
  • Patent number: 5077301
    Abstract: 4-(Hydroxydiphenylmethyl)-1-piperidylphenylalkane derivatives as antihistamines of the formula ##STR1## and pharmaceutically acceptable salts of such derivatives are disclosed in whichn is an integer between 0 and 2,R.sup.1 -R.sup.5 represent, independently of one another, hydrogen and at least one of them represents a linear or branched alkyl radical with 1-4 carbon atoms, a C.sub.1 -C.sub.3 -alkoxy radical or a hydroxyl radical. A method of treatment of allergic response in mammals is also disclosed.
    Type: Grant
    Filed: May 25, 1990
    Date of Patent: December 31, 1991
    Assignee: Schaper & Bruemmer GmbH & Co. KG
    Inventors: Eckhardt Pein, Helmut Ritter, Reinhard Laven
  • Patent number: 5047413
    Abstract: Certain acylated benzilic acid derivatives are useful for influencing therapeutically the tone of the urinary bladder in humans and animals. These derivatives are N-alkyl-4-piperidyl .alpha.,.alpha.-diphenyl-.alpha.-acyloxyacetates having the formula ##STR1## wherein R is H, CH.sub.3, C.sub.2 H.sub.5 or C.sub.3 H.sub.7 ; R' is H, NH.sub.2, phenyl, carboxyphenyl, (C.sub.1 -C.sub.6)alkyl, hydroxy(C.sub.1 -C.sub.6)alkyl, methoxy, ethoxy, methoxymethyl, ethoxymethyl, amino(C.sub.1 -C.sub.6)alkyl which can be substituted in the alkyl radical by one or more of a --NH.sub.2, --COOH or --SCH.sub.3 group, N-acetylamino(C.sub.1 -C.sub.6)alkyl, or a group having the formula--CH.dbd.CH--COOR"or--(CH.sub.2).sub.n --COOR"where n is an integer from 0 to 8, and R" is H, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, or a pharmacologically acceptable cation; or a salt thereof with a pharmaceutically acceptable acid.
    Type: Grant
    Filed: March 19, 1990
    Date of Patent: September 10, 1991
    Assignee: Schaper & Bruemmer GmbH & Co., KG
    Inventors: Eckhart Pein, Helmut Ritter, Reinhard Laven
  • Patent number: 4933459
    Abstract: Certain acylated benzilic acid derivatives are useful for influencing therapeutically the tone of the urinary bladder in humans and animals. These derivatives are N-alkyl-4-piperidyl .alpha.,.alpha.-diphenyl-.alpha.-acyloxyacetates having the formula ##STR1## wherein R is H, CH.sub.3, C.sub.2 H.sub.5 or C.sub.3 H.sub.7 ; R' is H, NH.sub.2, phenyl, carboxyphenyl, (C.sub.1 -C.sub.6)alkyl, hydroxy(C.sub.1 -C.sub.6)alkyl, methoxy, ethoxy, methoxymethyl, ethoxymethyl, amino (C.sub.1 -C.sub.6)alkyl which can be substituted in the alkyl radical by one or more of a --NH.sub.2, --COOH or --SCH.sub.3 group, N-acetylamino (C.sub.1 -C.sub.6)alkyl, or a group having the formula--CH.dbd.CH--COOR" or --(CH.sub.2).sub.n --COOR"where n is an integer from 0 to 8, and R" is H, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, or a pharmacologically acceptable cation; or a salt thereof with a pharmaceutically acceptable acid.
    Type: Grant
    Filed: December 16, 1988
    Date of Patent: June 12, 1990
    Assignee: Schaper & Bruemmer GmbH & Co., KG
    Inventors: Eckhart Pein, Helmut Ritter, Reinhard Laven